INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION (EIN 920169401) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

VIRGINA MASON

Phone

2512816993

Tax Period

2024-01-01 to 2024-12-31

INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION, founded in 1999, is a micro nonprofit in the Medical Research sector that reported $63K in total revenue in fiscal year 2024. Revenue fell 83% from the prior year — a significant decline worth monitoring. Expenses of $72K exceeded revenue, resulting in a 14% operating deficit.

Mission

BRINGING PATIENTS AND RESERCHERS TOGETHER

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $67,360

Program Service Revenue $0

Investment Income $-3,999

Other Revenue $0

TOTAL REVENUE $63,361

Expense Breakdown

Grants Paid $56,126

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $72,002

Other Expenses $15,876

TOTAL EXPENSES $72,002

Year-over-Year Comparison

	2024	2023	Change
Revenue	$63,361	$381,094	-0.8%
Expenses	$72,002	$38,909	+0.9%
Net Income	$-8,641	$342,185	-1.0%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JENNIFER CORDTS	DIRECTOR	5.00	Director	$0	$0	$0
BRYON DAVIS	DIRECTOR	5.00	Director	$0	$0	$0
PHYLLIS JOHNSON	VICE PRESIDE	5.00	Director	$0	$0	$0
VIRGINA MASON	PRESIDENT	40.00	Officer Director	$0	$0	$0
CAROL MCWILLIAMS	SECRETARY	20.00	Director	$0	$0	$0
ROY MOORE	DIRECTOR	N/A	Director	$0	$0	$0
JENNIFER SICKELS	TREASURER	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$63,361	$72,002	$1,142,135	$-8,641
2023	$381,094	$38,909	$1,154,301	$342,185
2022	$260,433	$32,327	$807,875	$228,106
2021	$189,670	$24,310	$579,309	$165,360
2020	$74,648	$35,608	$413,949	$39,040

INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION